Cargando…
HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis
Human Papillomavirus (HPV) is the most common sexually transmitted infection. Its progression is related to the development of malignant lesions, particularly cervical intraepithelial neoplasias (CINs). CINs correlate with a higher risk of premature births, and their excisional and ablative treatmen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402448/ https://www.ncbi.nlm.nih.gov/pubmed/34451941 http://dx.doi.org/10.3390/vaccines9080816 |
_version_ | 1783745792147718144 |
---|---|
author | Basile, Michele Calabrò, Giovanna Elisa Ghelardi, Alessandro Ricciardi, Roberto De Vincenzo, Rosa Cicchetti, Americo |
author_facet | Basile, Michele Calabrò, Giovanna Elisa Ghelardi, Alessandro Ricciardi, Roberto De Vincenzo, Rosa Cicchetti, Americo |
author_sort | Basile, Michele |
collection | PubMed |
description | Human Papillomavirus (HPV) is the most common sexually transmitted infection. Its progression is related to the development of malignant lesions, particularly cervical intraepithelial neoplasias (CINs). CINs correlate with a higher risk of premature births, and their excisional and ablative treatment further increases this risk in pregnant women. These complications are also correlated with higher healthcare costs for their management. In Italy, more than 26,000 new cases of CINs are estimated to occur yearly and their economic burden is significant. Therefore, the management of these conditions is a public health priority. Since HPV vaccination is associated with a reduced risk of relapse in women surgically treated for HPV-related injuries, we estimated the economic impact of extending HPV vaccination to this target population. This strategy would result in a significant reduction in the general costs of managing these women, resulting in an overall saving for the Italian Health Service of €155,596.38 in 5 years. This lower cost is due not only to the reduced incidence of CINs following vaccination, but also to the lower occurrence of preterm births. Extending HPV vaccination to this target population as part of a care path to be offered to women treated for HPV injuries is therefore desirable. |
format | Online Article Text |
id | pubmed-8402448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84024482021-08-29 HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis Basile, Michele Calabrò, Giovanna Elisa Ghelardi, Alessandro Ricciardi, Roberto De Vincenzo, Rosa Cicchetti, Americo Vaccines (Basel) Article Human Papillomavirus (HPV) is the most common sexually transmitted infection. Its progression is related to the development of malignant lesions, particularly cervical intraepithelial neoplasias (CINs). CINs correlate with a higher risk of premature births, and their excisional and ablative treatment further increases this risk in pregnant women. These complications are also correlated with higher healthcare costs for their management. In Italy, more than 26,000 new cases of CINs are estimated to occur yearly and their economic burden is significant. Therefore, the management of these conditions is a public health priority. Since HPV vaccination is associated with a reduced risk of relapse in women surgically treated for HPV-related injuries, we estimated the economic impact of extending HPV vaccination to this target population. This strategy would result in a significant reduction in the general costs of managing these women, resulting in an overall saving for the Italian Health Service of €155,596.38 in 5 years. This lower cost is due not only to the reduced incidence of CINs following vaccination, but also to the lower occurrence of preterm births. Extending HPV vaccination to this target population as part of a care path to be offered to women treated for HPV injuries is therefore desirable. MDPI 2021-07-22 /pmc/articles/PMC8402448/ /pubmed/34451941 http://dx.doi.org/10.3390/vaccines9080816 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Basile, Michele Calabrò, Giovanna Elisa Ghelardi, Alessandro Ricciardi, Roberto De Vincenzo, Rosa Cicchetti, Americo HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis |
title | HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis |
title_full | HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis |
title_fullStr | HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis |
title_full_unstemmed | HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis |
title_short | HPV Vaccination in Women Treated for Cervical Intraepithelial Neoplasia: A Budget Impact Analysis |
title_sort | hpv vaccination in women treated for cervical intraepithelial neoplasia: a budget impact analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402448/ https://www.ncbi.nlm.nih.gov/pubmed/34451941 http://dx.doi.org/10.3390/vaccines9080816 |
work_keys_str_mv | AT basilemichele hpvvaccinationinwomentreatedforcervicalintraepithelialneoplasiaabudgetimpactanalysis AT calabrogiovannaelisa hpvvaccinationinwomentreatedforcervicalintraepithelialneoplasiaabudgetimpactanalysis AT ghelardialessandro hpvvaccinationinwomentreatedforcervicalintraepithelialneoplasiaabudgetimpactanalysis AT ricciardiroberto hpvvaccinationinwomentreatedforcervicalintraepithelialneoplasiaabudgetimpactanalysis AT devincenzorosa hpvvaccinationinwomentreatedforcervicalintraepithelialneoplasiaabudgetimpactanalysis AT cicchettiamerico hpvvaccinationinwomentreatedforcervicalintraepithelialneoplasiaabudgetimpactanalysis |